Production (Stage)
KORU Medical Systems, Inc.
KRMD
$2.66
-$0.06-2.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.65% | 17.99% | 11.57% | 4.70% | 0.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.65% | 17.99% | 11.57% | 4.70% | 0.96% |
| Cost of Revenue | 9.87% | 4.28% | -2.68% | -11.06% | -11.35% |
| Gross Profit | 26.10% | 27.67% | 22.15% | 17.16% | 11.14% |
| SG&A Expenses | 9.54% | 6.22% | 3.50% | 0.00% | -1.19% |
| Depreciation & Amortization | -1.58% | 2.10% | 9.12% | 14.86% | 28.60% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.02% | 3.36% | -0.54% | -4.52% | -3.16% |
| Operating Income | 37.55% | 37.23% | 33.35% | 30.81% | 14.35% |
| Income Before Tax | 39.30% | 37.96% | 35.79% | 33.81% | 17.16% |
| Income Tax Expenses | -99.94% | -99.93% | 384.74% | 373.14% | 327.94% |
| Earnings from Continuing Operations | 60.07% | 55.85% | -45.08% | -45.01% | -55.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 60.07% | 55.85% | -45.08% | -45.01% | -55.44% |
| EBIT | 37.55% | 37.23% | 33.35% | 30.81% | 14.35% |
| EBITDA | 40.01% | 39.64% | 36.96% | 34.53% | 17.31% |
| EPS Basic | 60.22% | 55.98% | -44.51% | -44.26% | -53.92% |
| Normalized Basic EPS | 39.78% | 38.06% | 35.69% | 33.80% | 17.54% |
| EPS Diluted | 60.22% | 55.98% | -44.51% | -42.03% | -47.81% |
| Normalized Diluted EPS | 39.78% | 38.06% | 35.69% | 33.80% | 17.54% |
| Average Basic Shares Outstanding | 0.47% | 0.44% | 0.52% | 0.73% | 1.00% |
| Average Diluted Shares Outstanding | 0.47% | 0.44% | 0.52% | 0.73% | 1.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |